Michaelg Kauffman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michaelg kauffman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michaelg Kauffman Today - Breaking & Trending Today

KPTI Stock Price | Karyopharm Therapeutics Inc. Stock Quote (U.S.: Nasdaq)

KPTI | Complete Karyopharm Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ....

Joseph Araujo , Ronalda Depinho , Michaelg Kauffman , Its Selective Inhibitor Of Nuclear Export , Karyopharm Therapeutics Inc , Karyopharm Therapeutics , Selective Inhibitor , Nuclear Export , Giulio Draetta , Sharon Shacham , Pti Analyst Estimates , Pti Earnings Estimates , Pti Share Estimates , Pti Analyst Recommendations , Pti Ratings , Aryopharm Therapeutics Inc Analyst Estimates , Aryopharm Therapeutics Inc Earnings Estimates , Aryopharm Therapeutics Inc Analyst Recommendations , Aryopharm Therapeutics Inc Analyst Ratings ,

SIRTLab Corporation Appoints Michael G. Kauffman, MD, PhD, as Co-Chairman of the Board of Directors and Chief Medical Officer

/PRNewswire/ SIRTLab Corporation, a pioneer in the manipulation of sirtuin proteins for the treatment of severe liver diseases and longevity, today. ....

Harvard University , United States , Tel Aviv , Michaelg Kauffman , Hagit Ashush , Amir Shukrun , David Sinclair , Chaim Cohen , Michael Kauffman , Boaz Misholi , Karyopharm Therapeutics Inc , Sirtlab Corporation , Harvard Medical School , Bar Ilan University , Predix Pharmaceuticals Inc , Johns Hopkins Medical School , Proteolix Inc , Source Sirtlab Corporation , Pharmaceuticals Inc , Onyx Pharmaceuticals Inc , Development Program At Millennium Pharmaceuticals , Prnewswire Sirtlab Corporation , Bar Ilan University In Tel Aviv , Chief Medical Officer , Professor Haim Cohen , Chief Scientist ,

SIRTLab Corporation Appoints Michael G. Kauffman, MD, PhD, as Co-Chairman of the Board of Directors and Chief Medical Officer

/PRNewswire/ SIRTLab Corporation, a pioneer in the manipulation of sirtuin proteins for the treatment of severe liver diseases and longevity, today. ....

Harvard University , United States , Tel Aviv , Michaelg Kauffman , Hagit Ashush , Amir Shukrun , David Sinclair , Chaim Cohen , Michael Kauffman , Boaz Misholi , Karyopharm Therapeutics Inc , Sirtlab Corporation , Harvard Medical School , Bar Ilan University , Predix Pharmaceuticals Inc , Johns Hopkins Medical School , Proteolix Inc , Source Sirtlab Corporation , Pharmaceuticals Inc , Onyx Pharmaceuticals Inc , Development Program At Millennium Pharmaceuticals , Prnewswire Sirtlab Corporation , Bar Ilan University In Tel Aviv , Chief Medical Officer , Professor Haim Cohen , Chief Scientist ,

Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress

Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Adicet Bio , Michaelg Kauffman , Janhavi Mohite , Michael Kauffman , Anne Bowdidge , Chen Schor , Adicet Bio Inc , Regeneron Pharmaceuticals , Regeneron Pharmaceuticals Inc , Stern Investor Relations Inc , Company Board Of Directors , Society For Immunotherapy Of Cancer , Exchange Commission , Development Rd Expenses , Kezar Life Sciences , Chief Executive Officer , Recent Operational Highlights , Graft Versus Host Disease , Translational Immunology , Karyopharm Therapeutics , Verastem Oncology , Preclinical Data , Meeting The , Fourth Quarter , Full Year , Ended December ,

Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer

Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer
Richard Paulson, Recent Chief Executive Officer of Ipsen North America and Former Vice President and General Manager of Oncology at Amgen, Brings Wealth of Commercial Leadership and Global Strategic Experience
Michael G. Kauffman to Remain on Board of Directors and Assume New Role as Senior Clinical Advisor
News provided by
Share this article
Share this article
NEWTON, Mass., May 3, 2021 /PRNewswire/ Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of Richard Paulson as Karyopharm s President and Chief Executive Officer, effective May 3, 2021. Mr. Paulson will also remain a member of the Board of Directors. He will succeed Michael G. Kauffman, MD, PhD, as Chief Executive Officer and Sharon Shacham, PhD, MBA, as President. Dr. Kauffman will continue in ....

United States , South Africa , Czech Republic , Ian Karp , Richard Paulson , Michaelg Kauffman , Barry Greene , Andrew Lee , Sharon Shacham , Company Scientific Advisory Board , Takeda Pharmaceutical Company , University Of Saskatchewan , University Of Toronto , Company As Senior Clinical Advisor , Pfizer Inc , Karyopharm Selective Inhibitor Of Nuclear Export , European Union , Karyopharm Therapeutics Inc , Drug Administration , European Commission , Prnewswire Karyopharm Therapeutics Inc , Exchange Commission , Corporate Governance Compliance Committee , Ipsen Pharmaceuticals Inc , Chief Executive Officer , Senior Clinical ,